Clinical trial Recruiting at 7 sites Interventional Ages 18 to 69

Quality of Life Improvement for Patients with Resistant OCD Using Deep Brain Stimulation

Official title: European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS Versus Best Medical Treatment

Run by University Hospital, Grenoble · NCT02844049 · Data updated 2026-11-12

This study is testing if Deep Brain Stimulation can help people with severe OCD who haven't found relief from other treatments feel better and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years to 69 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity Hospital, Grenoble
Academic / other
Locations8 sites (Créteil and 7 other locations)
StatusRecruiting
StartedSeptember 2016
Main results expectedJuly 2026
Study endsApril 2027
Registry record updatedNovember 29, 2023
Trial IDNCT02844049 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with OCD for over five years who have not responded to multiple standard treatments.

Probably not a fit

Patients with specific OCD symptoms like hoarding or those with a history of psychosis or severe personality disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of Deep Brain Stimulation (DBS) on patients with Obsessive-Compulsive Disorder (OCD) who have not responded to traditional treatments. It aims to assess not only the clinical improvement in symptoms but also the overall quality of life of participants, which is often overlooked in standard treatment evaluations. The study will also explore potential biomarkers that could predict which patients are most likely to benefit from DBS. By focusing on a larger cohort, the research seeks to validate the effectiveness of this innovative surgical approach in enhancing patients' functional status and well-being.

Why it matters

Potential benefit: If successful, this study could significantly improve the quality of life for patients suffering from treatment-resistant OCD.

How similar studies have gone: Other studies have shown promising results with DBS for OCD, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* OCD for \> 5 years
* YBOCS\> 25 and/or YBOCS sub-scale \>15
* GAF\< 45
* 3 or more documented SRI trials, including clomipramine (10-12 weeks at adequate dose)
* SRI augmentation for \> 4 weeks with at least one antipsychotic and with one of the following: lithium, clonazepam
* Adequate trial of CBT (Exposure Therapy and Response Prevention) (intolerance or \>15 sessions)
* Ability to provide informed consent

Exclusion Criteria:

* Hoarding (if the only OCD symptom)
* OCD with poor insight (BABS score \> 12)
* Lifetime diagnosis of psychosis or bipolar disorder;
* Substance abuse or dependence within the previous six months;
* Baseline Montgomery and Asberg (MADRS) suicidality item (item 10) score \>2;
* Current DSM-5 personality disorder of Cluster A (e.g., paranoid or schizotypal personality disorder) or B (e.g., borderline or antisocial personality disorder);
* Brain pathology, such as moderate or marked cerebral atrophy, stroke, tumor or previous neurosurgical procedures (i.e. capsulotomy etc), history of cognitive impairment and cognitive deterioration (Addenbrooke's Cognitive Examination ACE score of \< 80).
* Contra-indications to surgery, anaesthesia, or MRI
* compulsory hospitalization/ care; pregnant or nursing patients

Where it's running

  • University Hospital of Grenoble Michallon
    Grenoble, France
    Recruiting
  • Chu Nice - Hopital Pasteur
    Nice, France
    Recruiting
  • APHP La Pitié Salpêtrière
    Paris, France
    Recruiting
  • Ghu Sainte Anne
    Paris, France
    Recruiting
  • Universitätsklinikum Köln (AöR)
    Cologne, Germany
    Recruiting
  • Djurfeldt
    Stockholm, Sweden
    Recruiting
Show 2 more locations
  • Hôpitaux Universitaires de Genève
    Geneva, Switzerland
    Recruiting
  • CHU Henri Mondor
    Créteil, France
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.